Fisher & Paykel Healthcare Corp Ltd FSPKF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if FSPKF is a good fit for your portfolio.
News
Trading Information
- Previous Close Price
- $18.25
- Day Range
- $17.23–17.58
- 52-Week Range
- $12.00–18.51
- Bid/Ask
- $17.05 / $20.83
- Market Cap
- $10.27 Bil
- Volume/Avg
- 363 / 1,102
Key Statistics
- Price/Earnings (Normalized)
- 80.54
- Price/Sales
- 9.63
- Dividend Yield (Trailing)
- 1.45%
- Dividend Yield (Forward)
- 1.45%
- Total Yield
- 1.45%
Company Profile
Fisher & Paykel Healthcare is one of the three largest respiratory care device companies globally. It is the market leader in hospital use humidifiers, masks and related consumables and the number three player in the at-home treatment of sleep apnea using respiratory devices. Both the hospital and homecare markets for respiratory devices are growing strongly in the developed markets in which Fisher & Paykel has a presence. The company earns 42% of its revenue in the US, 32% in Europe, 18% in Asia-Pacific and the remaining 8% in emerging markets. Fisher conducts its own R&D and has thousands of patents and pending applications. It manufactures in New Zealand and Mexico and has a multichannel distribution model.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Stock Style Box
- Large Growth
- Total Number of Employees
- 7,375
- Website
- https://www.fphcare.com
Competitors
Valuation
|
Metric
|
FSPKF
|
PHIA
|
RMD
|
|---|---|---|---|
Price/Earnings (Normalized) | 80.54 | 18.56 | 28.36 |
Price/Book Value | 9.79 | 1.85 | 6.47 |
Price/Sales | 9.63 | 1.29 | 6.62 |
Price/Cash Flow | 39.42 | 27.02 | 23.81 |
Price/Earnings
FSPKF
PHIA
RMD
Financial Strength
|
Metric
|
FSPKF
|
PHIA
|
RMD
|
|---|---|---|---|
Quick Ratio | 0.88 | 0.74 | 1.32 |
Current Ratio | 1.83 | 1.20 | 3.04 |
Interest Coverage | 13.77 | −1.60 | 22.63 |
Quick Ratio
FSPKF
PHIA
RMD
Profitability
|
Metric
|
FSPKF
|
PHIA
|
RMD
|
|---|---|---|---|
Return on Assets (Normalized) | 11.54% | — | 15.75% |
Return on Equity (Normalized) | 15.07% | — | 24.94% |
Return on Invested Capital (Normalized) | 13.94% | — | 19.33% |
Return on Assets
FSPKF
PHIA
RMD
Medical Instruments & Supplies Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Intuitive Surgical Inc
ISRG
| Rcrqdbqv | Kxqv | $156.8 Bil | |||
| Becton Dickinson & Co
BDX
| Bcnkldqk | Tlddpdk | $68.6 Bil | |||
| Alcon Inc
ALC
| Lvlxhjb | Tfnph | $46.5 Bil | |||
| Coloplast A/S ADR
CLPBY
| Cdvnbcnyv | Jgtb | $29.1 Bil | |||
| ResMed Inc
RMD
| Mmlmzlyn | Nkpkc | $28.9 Bil | |||
| West Pharmaceutical Services Inc
WST
| Fxbsdsnw | Qhcc | $20.7 Bil | |||
| The Cooper Companies Inc
COO
| Gkjzkbbk | Bxgvkj | $18.6 Bil | |||
| Hologic Inc
HOLX
| Qczvtkjxw | Gspjrr | $18.4 Bil | |||
| Baxter International Inc
BAX
| Npqlcqrg | Twpnb | $18.1 Bil | |||
| Teleflex Inc
TFX
| Yrgz | Dqwl | $10.4 Bil |